Full Professor(heuristic)

Cancer-related molecular mechanisms research · Cancer Research

Compare more Cancer Research professors.

h-index43
i10-index92
Publications162
Citations16,371

Grants

6 total · 4 active

NIH #R01CA255196

A novel lncRNA-responsive and xenobiotic receptor-mediated regulation of drug metabolism and disposition

Expiring Soon
Amount
$300K–$400K
Period
2020-12-01 → 2026-11-30
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NSF #2048268

CAREER: Exploring the Role of Vapor Buoyancy in Clouds, Circulation and Climate

Expiring Soon
Amount
$800K–$900K
Period
2021-10-01 → 2026-09-30
PIs
1

Awarded at University of California-Davis

NIH #R01CA282704

Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis

Active
Amount
$400K–$500K
Period
2023-09-01 → 2028-08-31
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 4 active

NIH #R01CA255196

A novel lncRNA-responsive and xenobiotic receptor-mediated regulation of drug metabolism and disposition

Expiring Soon
Amount
$300K–$400K
Period
2020-12-01 → 2026-11-30
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NSF #2048268

CAREER: Exploring the Role of Vapor Buoyancy in Clouds, Circulation and Climate

Expiring Soon
Amount
$800K–$900K
Period
2021-10-01 → 2026-09-30
PIs
1

Awarded at University of California-Davis

NIH #R01CA282704

Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis

Active
Amount
$400K–$500K
Period
2023-09-01 → 2028-08-31
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #R01CA272866

LncRNA EPIC1 induces immunotherapy resistance by activating EZH2 in breast cancer

Active
Amount
$300K–$400K
Period
2023-08-01 → 2028-07-31
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #R43DK139922

Targeting endogenous retrovirus Gag genes for biomarker development in type 1 diabetes

Amount
$200K–$300K
Period
2025-09-15 → 2026-08-31
PIs
1

Awarded at BIOSETTIA, INC.

NIH #R01HG012425

Genomic discovery and prediction for quantitative traits with complex genetic mechanisms

Amount
$200K–$300K
Period
2022-02-01 → 2026-01-31
PIs
1

Awarded at UNIVERSITY OF MINNESOTA

Recent Public Signals

  1. New paper: An Integrative Drug‐Induced Transcriptomic Analysis Identifies Novel MYC Antagonists and Potential Synergistic Drug Combinations (Molecular Carcinogenesis)2025-09-30
  2. New preprint: Development, Characterization and Rapid Diagnostics of an Aircraft Aerosol Mass Spectrometer Inlet System2025-02-24
  3. New NIH award: Enhancer RNAs Boost MYC-Chromatin Interaction to Regulate Gene Expression and Tumorigenesis2023-09-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-8336-9457

Professor Insights

Career Trajectory